1. Schneider, Sophia, Schierbaum, Luca, Burger, Wessel A C, Thal, David M, Hildebrandt, Friedhelm. 2023. Recessive CHRM5 variant as a potential cause of neurogenic bladder. In American journal of medical genetics. Part A, 191, 2083-2091. doi:10.1002/ajmg.a.63241. https://pubmed.ncbi.nlm.nih.gov/37213061/
2. Anney, Richard J L, Lotfi-Miri, Mehrnoush, Olsson, Craig A, Hemphill, Sheryl A, Patton, George C. 2007. Variation in the gene coding for the M5 muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults. In BMC genetics, 8, 46. doi:. https://pubmed.ncbi.nlm.nih.gov/17608938/
3. Sakata, Kazuko, Overacre, Abigail E. 2017. Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments. In Journal of neurochemistry, 143, 49-64. doi:10.1111/jnc.14129. https://pubmed.ncbi.nlm.nih.gov/28722769/
4. Vyavahare, Sagar, Ahluwalia, Pankaj, Gupta, Sonu Kumar, Isales, Carlos M, Fulzele, Sadanand. 2024. The Role of Aryl Hydrocarbon Receptor in Bone Biology. In International journal of tryptophan research : IJTR, 17, 11786469241246674. doi:10.1177/11786469241246674. https://pubmed.ncbi.nlm.nih.gov/38757095/
5. Mann, Phyllis E. 2014. Gene Expression Profiling during Pregnancy in Rat Brain Tissue. In Brain sciences, 4, 125-35. doi:10.3390/brainsci4010125. https://pubmed.ncbi.nlm.nih.gov/24961703/